Director of the Board @ Agb Pharma Development (January 2020 - Present)
Partner @ (January 2018 - January 2020)
Director of the Board @ Reccan Diagnostics (January 2016 - January 2020)
Chairman of the Board @ (January 2018 - Present)
Head Experimental Medicine, Bioanalysis, Clinical Pharmacology and Pk @ (January 2009 - January 2017)
Adjunct Professor @ (January 2014 - Present)
Head Early Development Clinical Neuroscience, MSD @ (January 2006 - January 2009)
Ta Head Neuroscience, Exploratory Clin Development @ (January 2003 - January 2006)
Director @ (January 1997 - January 2003)
Life Science Consultant @ In Manu Medici Lg Ab (January 1993 - Present)
Lars Grundemar Education
(Pharmacology)
Lars Grundemar Skills
Clinical Development
Oncology
Drug Development
Neuroscience
Endocrinology
Clinical Research
Therapeutic Areas
Clinical Trials
CRO
Pharmacology
Drug Discovery
Pharmaceutical Industry
Clinical Pharmacology
Pharmacovigilance
Pharmaceutics
Medical Affairs
GCP
CTMS
Medical Writing
Urology
Regulatory Affairs
Translational Medicine
Regulatory Submissions
Biopharmaceuticals
Biomarkers
Lifesciences
Medical Research
Biotechnology
Pharmaceutical Research
Pharmacokinetics
Market Access
Life Sciences
CRO Management
Good Clinical Practice Gcp
Good Clinical Practice
Lars Grundemar Summary
Lars Grundemar, based in Lund, SE, is currently a Deputy Chief Executive Officer and Chief Medical Officer at AGB-Pharma AB. Lars Grundemar brings experience from previous roles at Oncorena Ab, Agb Pharma Development, Ventac Partners and Reccan Diagnostics. With a robust skill set that includes Clinical Development, Oncology, Drug Development, Neuroscience, Endocrinology and more. Lars Grundemar has 4 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Lars Grundemar?
Find contact details for 700 million professionals.